Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2024 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
November 28, 2023 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Onconova presenting at NobleCon19 Dec 4-5 in Boca Raton, FL
November 14, 2023 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results

Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
November 07, 2023 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
October 24, 2023 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Expands Leadership Team with Two Key Appointments

Onconova Expands Leadership Team: Victor Moyo named Chief Medical Officer, Meena Arora joins as Vice President Global Medical Affairs and R&D
October 12, 2023 08:00 ET | Source: Onconova Therapeutics, Inc.

Encouraging Rigosertib Data Presented at EADV as Late Breaker

NEWTOWN, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on...
September 28, 2023 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress

NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and...
September 06, 2023 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

NEWTOWN, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and...
August 10, 2023 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results

Anticipate topline results from the Phase 1 monotherapy and Phase 1/2 combination study with letrozole in Q4 2023 Plans are underway for a registrational trial with rigosertib in patients with...
August 03, 2023 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023

NEWTOWN, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and...